# Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)

> **NCT06919991** · PHASE1 · COMPLETED · sponsor: **Arcus Biosciences, Inc.** · enrollment: 14 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Casdatifan
- **DRUG:** Itraconazole
- **DRUG:** Phenytoin

## Key facts

- **NCT ID:** NCT06919991
- **Lead sponsor:** Arcus Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-02
- **Primary completion:** 2025-10-18
- **Final completion:** 2025-10-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06919991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06919991, "Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06919991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*